SNDX

12.01

2.24% -0.275

Pre-mercato: 12.29 0.28 +2.33%

Syndax Pharmaceuticals Inc (SNDX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$12.29

Aprire:

$12.2

Volume 24 ore:

2.66M

Relative Volume:

1.36

Capitalizzazione di mercato:

$1.03B

Reddito:

$139.71M

Utile/perdita netta:

$-209.36M

Rapporto P/E:

-4.0574

EPS:

-2.96

Flusso di cassa netto:

$-160.60M

1 W Prestazione:

-10.64%

1M Prestazione:

-23.21%

6M Prestazione:

-39.62%

1 anno Prestazione:

-49.50%

Intervallo 1D:

$11.62

$12.25

Intervallo di 1 settimana:

$11.62

$13.80

Portata 52W:

$11.62

$25.07

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Nome

Syndax Pharmaceuticals Inc

Settore

Healthcare (1165)

Industria

Biotechnology (681)

Telefono

781-419-1400

Indirizzo

35 GATEHOUSE DRIVE, WALTHAM, MA

Dipendente

184

Cinguettio

@syndax

Prossima data di guadagno

2025-03-03

Ultimi documenti SEC

SNDX's Discussions on Twitter

Confronta SNDX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SNDX Syndax Pharmaceuticals Inc	12.01	1.03B	139.71M	-209.36M	-160.60M	-2.96
VRTX Vertex Pharmaceuticals Inc	484.74	124.48B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	617.00	67.45B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	567.09	34.59B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	255.76	33.10B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	271.04	29.15B	3.81B	-644.79M	-669.77M	-6.24

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-10-24	Iniziato	UBS	Buy
2024-06-28	Iniziato	Jefferies	Buy
2024-01-31	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2023-12-22	Iniziato	Mizuho	Buy
2023-10-25	Iniziato	BofA Securities	Buy
2023-10-11	Iniziato	Goldman	Buy
2023-07-27	Iniziato	Scotiabank	Sector Outperform
2023-07-11	Iniziato	Guggenheim	Buy
2023-04-17	Ripresa	BTIG Research	Buy
2023-01-31	Iniziato	Stifel	Buy
2023-01-03	Iniziato	JP Morgan	Overweight
2022-07-28	Ripresa	B. Riley Securities	Buy
2022-04-11	Iniziato	H.C. Wainwright	Buy
2022-02-15	Iniziato	Goldman	Buy
2021-06-04	Ripresa	Robert W. Baird	Outperform
2021-05-25	Iniziato	Citigroup	Buy
2021-02-18	Iniziato	B. Riley Securities	Buy
2020-12-03	Iniziato	Stifel	Buy
2020-05-22	Aggiornamento	Citigroup	Neutral → Buy
2020-05-22	Downgrade	H.C. Wainwright	Buy → Neutral
2020-05-18	Downgrade	Citigroup	Buy → Neutral
2020-05-11	Reiterato	H.C. Wainwright	Buy
2020-03-04	Iniziato	Barclays	Overweight
2020-01-13	Reiterato	H.C. Wainwright	Buy
2019-03-08	Reiterato	H.C. Wainwright	Buy
2019-01-04	Iniziato	Robert W. Baird	Outperform
2018-01-05	Iniziato	B. Riley FBR, Inc.	Buy
2017-03-16	Iniziato	FBR & Co.	Outperform
2017-03-02	Iniziato	Instinet	Buy
2016-10-07	Iniziato	Guggenheim	Buy
2016-03-28	Iniziato	Citigroup	Buy
2016-03-28	Iniziato	JMP Securities	Mkt Outperform
2016-03-28	Iniziato	Morgan Stanley	Overweight

Mostra tutto

Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie

05:38 AM

Axiom Investors LLC DE Reduces Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

05:38 AM

03:43 AM

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Teacher Retirement System of Texas - Defense World

03:43 AM

02:23 AM

Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to Sell at StockNews.com - Defense World

02:23 AM

Apr 01, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 7.5%What's Next? - MarketBeat

Apr 01, 2025

Syndax stock touches 52-week low at $12.05 amid market challenges - Investing.com

Apr 01, 2025

Mar 27, 2025

Simplify Asset Management Inc. Purchases 25,456 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Mar 27, 2025

Mar 25, 2025

What Do Analysts Think About Syndax Pharmaceuticals Inc’s (NASDAQ:SNDX) Future? - Stocks Register

Mar 25, 2025

Mar 24, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $41.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Mar 24, 2025

Mar 23, 2025

Long Term Trading Analysis for (SNDX) - news.stocktradersdaily.com

Mar 23, 2025

Charles Schwab Investment Management Inc. Purchases 8,876 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Mar 23, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Raised to $41.00 - Defense World

Mar 23, 2025

Mar 22, 2025

Syndax Pharmaceuticals’ 41% decline validates InvestingPro’s bearish call By Investing.com - Investing.com UK

Mar 22, 2025

Mar 21, 2025

Syndax's Revuforj Earns Strong Physician Support, JP Morgan Predicts Sales Growth - Benzinga

Mar 21, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 5.5% Higher Following Analyst Upgrade - MarketBeat

Mar 21, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 5.5% on Analyst Upgrade - Defense World

Mar 21, 2025

Bank of New York Mellon Corp Increases Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Mar 21, 2025

Mar 18, 2025

US Bancorp DE Reduces Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Mar 18, 2025

Mar 17, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $36.00 Average Price Target from Analysts - MarketBeat

Mar 17, 2025

Mar 13, 2025

Syndax at Barclays Healthcare Conference: Strategic Vision for Menin Inhibitors - Investing.com UK

Mar 13, 2025

Syndax Pharmaceuticals’ SWOT analysis: stock soars on FDA approvals, faces profitability hurdles By Investing.com - Investing.com South Africa

Mar 13, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Mar 13, 2025

Mar 12, 2025

Syndax Pharmaceuticals’ SWOT analysis: stock soars on FDA approvals, faces profitability hurdles - Investing.com India

Mar 12, 2025

Graft Versus Host Disease Market Expected to rise, 2034 | Biocon, medac GmbH, MaaT Pharma, ElsaLys Biotech, Glia, Syndax Pharmaceuticals, ASC Therapeutics, SCM Lifescience, REGiMMUNE, Roche, VectivBio - The Globe and Mail

Mar 12, 2025

Candriam S.C.A. Cuts Stock Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Mar 12, 2025

Mar 11, 2025

What Does Syndax Pharmaceuticals Inc’s (NASDAQ: SNDX) Future Hold? - Stocks Register

Mar 11, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 7.4% Following Weak Earnings - MarketBeat

Mar 09, 2025

Mar 08, 2025

JPMorgan Chase & Co. Issues Positive Forecast for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price - MarketBeat

Mar 08, 2025

Citigroup Issues Pessimistic Forecast for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price - MarketBeat

Mar 08, 2025

Syndax Pharmaceuticals' (SNDX) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Mar 08, 2025

Syndax Pharmaceuticals Reports 2024 Financial Results - MSN

Mar 08, 2025

Mar 07, 2025

Syndax Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

What is B. Riley’s Estimate for SNDX Q3 Earnings? - Defense World

Mar 07, 2025

What is HC Wainwright’s Forecast for SNDX FY2025 Earnings? - Defense World

Mar 07, 2025

Mar 06, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Announces Quarterly Earnings Results - MarketBeat

Mar 06, 2025

Strong Buy Rating for Syndax Pharmaceuticals Driven by Revuforj’s Market Potential and Revenue Growth - TipRanks

Mar 06, 2025

HC Wainwright Reiterates “Buy” Rating for Syndax Pharmaceuticals (NASDAQ:SNDX) - Defense World

Mar 06, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - Defense World

Mar 06, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Mar 06, 2025

Syndax Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025

What is B. Riley’s Forecast for SNDX Q1 Earnings? - Defense World

Mar 06, 2025

What is HC Wainwright’s Forecast for SNDX Q1 Earnings? - Defense World

Mar 06, 2025

Mar 05, 2025